Movatterモバイル変換


[0]ホーム

URL:


GB2178447A - A matrix for cell cultivation in vitro - Google Patents

A matrix for cell cultivation in vitro
Download PDF

Info

Publication number
GB2178447A
GB2178447AGB08614799AGB8614799AGB2178447AGB 2178447 AGB2178447 AGB 2178447AGB 08614799 AGB08614799 AGB 08614799AGB 8614799 AGB8614799 AGB 8614799AGB 2178447 AGB2178447 AGB 2178447A
Authority
GB
United Kingdom
Prior art keywords
matrix
cells
fibers
cell
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08614799A
Other versions
GB2178447B (en
GB8614799D0 (en
Inventor
Zvi Bohak
Avinoam Kadouri
Martin Sussman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co LtdfiledCriticalYeda Research and Development Co Ltd
Publication of GB8614799D0publicationCriticalpatent/GB8614799D0/en
Publication of GB2178447ApublicationCriticalpatent/GB2178447A/en
Application grantedgrantedCritical
Publication of GB2178447BpublicationCriticalpatent/GB2178447B/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

A matrix and cultivation system for anchorage dependent cells has a substantially increased available effective surface area for cell attachment provided by a fiber network or open-pore foams with suitable pore size of 10 mu to 100 mu . Attachment of the cells can be enhanced by modifying the surface of the substrate. One embodiment comprises a matrix in particle or flake form.

Description

SPECIFICATIONA matrix for cell cultivation in vitroField of the inventionThe present invention relates to the in vitro cultivation and growth of various of living cells, and in particular to methods and devices for in vitro growth of mammalian tissue cells that require (in addition to sterile liquid nutrient media) attachment to a solid surface in order to effectively grow, metabolize nutrients, reproduce, and produce biologically active materials. Such tissue cells are called "anchorage dependent" cells. The provision of suitable surfaces to which such cells will attach themselves, is an essential requisite for their in vitro cultivation.
Background of the inventionTissue cell culture is therefore carried out on solid continuous surfaces. On laboratory scale these are in the form of petri-dishes, flat sided bottle or roller bottles. Recent improvements, applicable also to large scale culture have been the development of spheres of various sizes such as microbeads, as well as of ceramic blocks traversed by small rectangular channels. In all these devices the cells adhere and propgate on the available surface of a solid.
Cells will attach only to surfaces that have suitable surface compositions and an electrical surface charge.
Materials that have proved successful for this purpose are glass, ceramics, polyvinyl chloride, polystyrene, dextran, collagen, and certain other materials. Frequently the cell attachment surfaces of such materials are treated with 95% sulfuric acid, or preferably with a corona or oxygen plasma discharge to improve cell adherence. Under culturing conditions such as those described in (Kruse & Patterson Tissue Culture - Methods and Applications, Academic Press 1983), cells coming in contact with these surfaces will attach themselves to the surface, and reproduce until they cover the surfaces in a contiguous, confluent monolayer. On reaching confluence cell growth ceases. The phenomenon of cell growth cessation when a contiguous layer of cells is achieved is called "contact inhibition" and is a characteristic of non-cancerous cell growth on two dimensional surfaces.
The growth surfaces used at present for in vitro tissue culture suffer from certain serious shortcomings:a) They provide limited area per unit volume of nutrient medium supplied, so that the number of cells that can be grown per unit volume of nutrient medium is as much as three orders of magnitude smaller than the volumetric densities of cells in in vitro tissue.
b) They require high concentrations of inoculated cells in order to initiate cell growth. Typically cells are introduced to a fresh culture surface at a concentration and number which is 20-30% of the final number reached at confluence and it is usually impossible to inoculate with less then 10% of the number reached at confluence.
c) Cell growth of non-cancerous cells limited to monolayers;d) Cells tend to detach from their anchorage surface under conditions that include: monolayer saturation; high or low serum concentration; medium depletion, and particularly, viscous shear caused by stirring or perfusion of the culture medium. Cell growth and biosynthesis stop on cell detachment.
Though non cancerous cells are grown on two dimenisonal surfaces, it has long been known that normal cells will also grow in gels, and specifically those of collagen. One such gel is available commerically (trade name "Gelfoam", Upjohn, Kalmazoo). Gels have however a poor dimensional stablility and, due to their internal structure are unsuitable for growing cells to a reasonable density and especially not for systems with medium perfusion. They have therefore not found use for the large scale culture of cells. Their use in limited to laboratory studies of cell morphology, or studies of the "hystotypic" growth of primary cultures (e.g. Dougles et al., In Vitro, 16, 306-312 (1980)).
Also relevant to this invention is the fact that certain cells and particularly cancerous mammalian cells and altered forms of cells such as hybridomas can be grown freely suspended in culture medium or immobilized in small beads of porous gelled material such as carrageenan, agarose, collagen, gelatin and similar starch or proteinor polymer materials. Cells may be mixed into such gels prior to casting the gels into the form of small beads orparticles that will be suspended in nutrient medium. (Karkare, S.B., Phillips, P.G., Burke, D.H., and Dean Jr., R.C.
"Continuous Production of Monoclonal Antibodies by Immobilized Hybridoma Culture" A.C.S. Annual MeetingPhila. Pa, Aug 27, 1984, available from Verax Corp. Hanover, N.H.).
Alternatively, cells may be immobilized in microcapsules as described by Lim et al., Microencapsulation ofLiving Cells and Tissues; J. Pharm. Sci., 70, 4: 351-354, April 1981; Nilsson., Entrapment of Animal Cells forProduction of Monoclonal Antibodies and other Biochemicals, Nature 302, 629-630, 1973.
The invention herein described also relates to the cultivation of such non-anchorage dependent cells and othercells whose growth and harvesting may be facilitated by some form of immobilization as described above.
Summary of the inventionAccording to the present invention htere are provided:A matrix for use in cell cultivation in vitro providing a high-surface-area substrate the effective area of which is from 10 to about 100 times the area of same projected onto a plane surface, comprising a physiologicallyacceptable network of fibers having a porosity of from 40 to about 95% and a pores size of the order of 10 p to100 p, or an open-pore foamed structure with a pore size of from about 10 p ot 100 p, the overall height of thematrix being of the order of from 50 p to about 500 p; A matrix where the 3-dimensional structure is one of a non-woven fabric from round, flat, non-round, or hollow fibers or combination of such fibers of the order of from 0.5 pm to 50 pm diameter or width;;A matrix where the structure is composed of ribbon formed fibers of 2 um to 20 pm width which may be crimped, and where the ratio of width to thickness is 2:1 or more;A matrix for anchorage dependent cell attachment that has a high surface density by which is meant a high specific surface area, or surface area per unit of projected surface or, high surface area per unit volume of surrounding medium;A surface that increases the density of cells grown per unit volume of medium by at least one order of magnitude greater than that achievable in flat plate cultures;A high specific surface cell attachment matrix that may be disposed as a flat sheet;A matrix that may be disposed as a spiral sheet or as corrugated sheets.;A matrix that may be disposed as suspended cell carrier in a stirred culture tank reactor;A matrix that can be easily sampled for determining cells numbers;;A matrix that can be easily samples for microscopic examination;A matrix that protects cells from impact and viscous shear;A matrix that inhibits detachment of cells from said surface;A matrix that permits cell growth to be initiated at low inoculation densities, and consequently permits cell densities and number to increase by more than 10 fold, thus reducing the number of cultures that need to be started to achieve high production of cells and cell products;A matrix that permits cell growth in multiple layers and in a three dimensional matrix;A matrix that permits cells to grow in three dimensional non-planar forms;A matrix that allows rapid inward diffusion of materials such as nutrients, hormones, growth factors and serum components and outward diffusion of metabolic wastes and cell products;;A matrix for growing anchorage-dependent or non-anchorage dependent cells, said matrix providing high internal surface area and high internal volume with pores that are 1 to 20 times the volume of individual cells, said pores being within 100 micrometer of the exterior surface of the matrix so as to provide rapid diffusion throughout and into and out of the matrix;A matrix for entrapping cells that are not anchorage-dependent, that facilitates the harvesting of such cells in suspension culture;A matrix for protecting and growing non-anchorage dependent cells at high density while exposed to fluid nutrients that are moving at high velocities and that are under high shear;A matrix for entrapping or anchoring cells that has a near neutral buoyancy so that particles made of this matrix may be suspended in nutrient medium with minimal amounts of stirring;;A matrix for anchoring or entrapping cells that has a variable buoyancy controlled by the pressure imposed on the cell culture vessel, so as to permit moving the matrix up and down through the nutrient liquid by lowering or raising the pressure in the cell culture vessel;A process for producing tissue plasminogen activator at high concentrations and in large volumes of culture, while conserving serum and preventing dilution of cell products in excess medium, and means for carrying our such process.
These and other objectives will became apparent from the following detailed disclosure.
General description of the inventionAccording to the invention there is provided a growth matrix that substantially increases the available attachment surface for the adherence of the cultivated cells: the increase is by a factor of from 10 to 30 times, calculated on the projection of the base on which structures of the invention are supported. Such an increase by a factor of 10 to 30 times, is per unit layer, and if a plurality of such layers, separated by spacers or the like, is used, the factor of 10 to 30 times applies per each such structure.When the matrix is used in sheet form, preferably non-woven fiber sheets, or sheets of open-pore framed polymers, the preferred thickness of the sheet is about 50 to 250 pom, there being provided adequate porosity for cell entrance, entrance of nutrients and for removal of waste products from the sheet said pores having an effective diameter of 10 pm to 100 vim. Such sheets can be be prepared from fibers of various thicknesses, the preferred fiber thickness or fiber diameter range being from 0.5 um to 20 pm, still more preferred being in the range of 10 pm to 15 pm diameter.
A plurality of such sheets can be used, stacked above each other, and in such case suitable spacing means are resorted to. A porous spacer of from 150 um to about a millimeter generally gives satisfactory results.
The structures of the invention may be supported by, or even better bonded to, a porous support sheet or screen providing for dimensional stability and physical strength.
Such matrix sheets may also be cut, punched, or shredded to provide particles with projected area of the order of about 0.2 mm2 to about 10 mm2, with the same order of thickness (about 50 to 250 pom), said particles being particularly useful in suspension of fluidized culture.
The present invention relates also to devices or matrices for entrapping and growing non-anchorage dependent cells in open encapsulation, providing a protected micro-environment for growth of cells and facilitating cell harvest.
To produce large quantities of non-anchorage dependent cells, the cells are usually grown in suspension in a nutrient liquid medium that is stirred to ensure that each cell is adequately bathed in nutrients, and that metabolic wastes are carried away from the cell. A certain fraction of the cells is destroyed by impact with the impeller or by high shear. Harvesting cells from conventional suspension culture requires special supplemental equipment such as centrifuges or micro-porous filters. Also cell concentration per cubic centimeter of nutrient liquid is relatively low.
One method of simplifying the harvesting of such cells and increasing their density involves encapsulating the cells in permeable microcapsules as described by the preciously cited works of Lim and Nilsson. These microcapsules are larger and denser than the cells they entrap. Consequently they are easily separated from the nutrient medium by settling or by filtration. The microcapsules have certain disadvantages:- they are costly and delicate to produce;- at high density growth, cells at the center of the capsule frequently die;- capsules may burst prematurely losing their content cells.
- each new inoculation requires a fresh encapsulation procedure.
The present invention pertains to the provision of forms of materials that provide improved surfaces and morphologies for cell attachment and/or entrapment during in vitro culture, said improved surfaces and morphologies overcoming the shortcomings of currently used attachment surfaces, as well as providing new capabilities for improved culture of other cells not requiring an anchorage surface.
Porous sheets as cell growth matricesWe have found that certain forms and composition of fibers and certain high porosity membranes provide highly effective supports for culturing cells and particularly anchorage dependent cells; particularly when said fibers are arranged in flat, highly porous, non-woven sheets, or mats, having an appearance like filter or tissue paper, or of thin porous felt. Said non-woven sheets can be made by any of the wide variety of well known techniques for making non-woven fabrics, papers, or felts, which include spin-bonding, thermal bonding, calendering, needling, etc., techniques. The sheets should preferably be free of glue or adhesive coatings not specifically used to promote cell adhesion to the fiber surfaces.
The fibers used to form the non-woven fiber sheets may be in the form of continuous filaments, staple filaments, hollow filaments, pulp, or floc, or combinations of such forms, and are preferably disposed in the sheet in a highly disordered, random-like, intertangled, manner; the axes of the fibers forming an open, multi-dimensional array. The porosity of the sheet should range from 40 to 95% with a preferred porosity of 60-80%. Preferred pore-size is between 10 and about 100 pom.
The individual fibers should have deniers (weight in grams of 9000 meters of fiber) of between 0.05 and 5 denier per filament (dpf) with a preferred weight of 1.0 to 1.5 dpf. Fiber cross-section may be round or not, with a preferred cross-section being that of a ribbon, that may in addition have a crimp imposed along its axis. Fiber width may range from 0.5 to 50 micrometers, but a preferred width is 10 to 15 micrometers. When hollow filaments are incorporated in the non-woven sheet, they may have single or multiple lumens and their denier will generally be greater than solid cross-section fiber, ranging as high as 50 denier per filament.
High porosity membranes suitable for this application must have a sponge-like structure and porosity, and pore dimensions similar to the non-woven fiber mats; that is 40 to 95% porosity and pore size between 10 and 80 micrometers. Pores must be opened and have high tortuosity. The polymer matrix should be continuous and can have any composition that promotes cell adhesion. Examples of polymers suitable for porous membrane growth are cellulose, cellulose acetate, polyethylene, polyesters, polyfluorochloroethylenes, polyvinylchlorides, polystyrenes, polysulfones, fiber glass, etc.
The thickness of the non-woven fiber sheet or porous membrane is an important parameter. Under proper culture conditions many cells inoculated on these sheets grow within the thickness of the sheet, rather than on the top surfaces of the sheet. Cells proliferate among the fibers of the sheet in three dimensions, rather than in two dimensions as in conventional tissue culture bottles, flasks, petri dishes and on microcarrier beads. Cells may attach themselves to more than one fiber (Figure 1) and cell growth thus takes place in the internal volume of the fiber matrix. The cells form a multilayered tissue-like structure whose thickness is that of the non-woven fiber sheet.To ensure adequate diffusion of nutirents and products to and from the interior of the cell aggregate and to prevent necrosis of cells in the interior of this dense structure, the sheet must be between about 25 and 250 vim thick. A preferred thickness is 100-150 pm. An ideal sheet thickness is approximately equal to the spacing of capillaries that occurs in vivo in the particular kind of tissue being cultured.
The non-woven porous growth matrix sheets may be used alone or they can be thermally bonded to rigid support materials that help the sheets retain their shape, or prevent the sheets from settling into dense contact with each other when used in a close packed array. A particularly useful configuration is to thermally laminate the growth matrix sheet to coarse (1 mm mesh) polypropylene screen (Figure 2). This also allows adjustment of the net density of the matrix so that it can be neutrally buoyant when used in a suspension culture.
The growth matrix sheets and the support and separator sheets may be provided with means to distribute liquid medium uniformly to all parts of a stack of such sheets and with means to promote the flow of medium parallel to the plane of each matrix sheet. Such means may be integral baffles or channelling orifices as shown by 20, and 21, in Figure 4a.
Growth matrix sheets can be used in many ways:- as liners on bottoms of petri dishes or on the inside surfaces of roller bottles, increasing growth surface area by more than one order of magnitude;- as spiral sheets inside roller bottles (Figure 3);- as in Figures 6 and 7, as sheets (11) laminated or layered external to and between flattened tubes (13) of permeable or microporous polymers wherein each alternate flattened tube serves as a conduit, the one for liquid nutrient medium (14), the other for gases (15) such as oxygen, air, CO2 and water vapor, the entire assembly being wound into a spiral as shown in Figure 6, or placed in a laminated interleaved stack (Figure 8) and immersed in a closed sterile container (16) Figure 7, filled with nutrient medium (17) and inoculated with cells for cultivation.Gases and nutrient medium are pumped through the flattened permeable tubes in a pulsatile fashion so that cells growing on the porous or non-woven fiber matrix sheet (11) are bathed in gently surging fluid that is never depleted of oxygen or nutrients and in which wastes do not accumulate through stagnation.
Four connections (Figures 6, 7, (18), generally running through the cover (19) of the assembly serve to introduce and remove gases, and nutrient medium to and from the flattened tubes (13). Probes for monitoring culture parameters such as PO2 (10), pH (11) and glucose concentration (12) may be placed in the growth medium (17) external to the flattened spiral tubes and used to control the nutrient (14) flow rate and composition, as well as the gas (15) CO2 and oxygen content. Polypropylene screens or similar spacers (12) are placed inside each flatted tube and between tubes to maintain minimum separation distances between each layer of the spiral or stack.Access to the cell growth matrix (11) and external or immersion growth medium (17) is made through ports (20) that may also be used to perfuse or remove the immersion medium, or for product collection, or for change of medium, or to samples cells.
- as packing in columns that are continuously perfused with medium, (Figure 4);- as microcarriers in suspension cultures replacing such materials as modified dextran beads. (Reference "Microcarrier Cell Culture" Pharmacia Chemicals, Uppsala, Sweden (1981)).
When used as microcarriers or as column packing the growth matrix is advantageously laminated to polyproplyene screen (as previously mentioned (Figure 2) that are then cut into small discs, squares, rings cruciforms, or corrugated and folded shapes, to give desired hydrodynamic characteristics to the packing or suspension material.
Alternatively the growth matrix material when used as microcarriers in suspension culture can be cut from fibrous non-woven sheets composed of mixtures of fibers whose density and relative proportions give the sheet a near neutral buoyancy. As an example, circular microdiscs having a diameter of 2 millimeters were stamped from a non-woven sheet composed of a ramdomly oriented mixture of 20 weight percent polyethylene terephthalate fibers and 80% fibers of polypropyline. Because the polyethylene terephthalate fibers had a specific gravity of 1.33 and the polypropylene fibers a specific gravity of 0.92, the composite non-woven fabric had a density of 1.002, so that microdiscs stamped from this sheet were kept suspended in liquid medium when stirred at much lower speeds then are required to maintain in suspension discs composed of solid polyethylene terephthalate fibers only.
Near neutral buoyancy microdiscs were also made by combining in suitable proportions hollow filament polymer fibers having gas filled lumens, with solid, low denier per filament polymer fibers (Figures 2a, 2b). The advantage of microcarriers bearing entrapped gas bubbles is that their buoyancy can be controlled. Because the volume of the entrapped gas increases or decreases as the external pressure on the suspension culture is decreased or increased, the microdiscs are made periodically to float and sink in the nutrient liquid without using an agitator or stirrer. This produces a very gentle washing action and is particularly effective for bringing nutrients to the surface of growing cells and removing metabolic wastes, with cell types that tend to become dislodged from attachment surfaces when stirred.It also eliminates the need for agitators and stirrers, simplifying and reducing the cost of large culture vessels.
A major advantage of this invention is the application of porous matrix cell attachment surfaces to microcarrier tissue cell "suspension culture" (Microcarrier suspension tissue cell culture procedures are described in "Microcarrier Cell Culture," Pharmacia Fine Chemicals, Uppsala, Sweden, (1981); and in the article "Large ScaleProduction of Tissue Cells" Scientific American Jan (1983)). For suspension culture application the porous sheet is cut into small pieces, each having a projected surface of between about 1 to 100 square millimeters, with a preferred projected area of about one to 20 square millimeters. The shape of said small pieces may take many forms, with a disc or circular form being preferred.The porous matrix cell attachment sheet material may be thermally bonded to materials such as polypropylene screening having a 1 mm or finer mesh, in order to strengthen the porous matrix material and also in order to increase its buoyancy as described previously. It is particularly advantageous to punch such discs using a heated die so that the fibers at the circumferential edge of the dsic are thermally bonded or partially fused to each other.
We have discovered on theorectical grounds and verified through experiments that such porous matrix microcarriers require substantially lower concentrations of inoculum (cells introduced at the start of a culture) to initiate successful cell growth. For example in a typical suspension culture of microcarriers (modified dextran beads), the inoculum contains 30% of the number of cells that are harvested at the end of the culture(Fleiscschaker, p. 117, Ph.D. Thesis, June 1982, M.I.T. Dept. of Nutrition and Food Science). We have discovered that when polyester fiber porous matrix microcarriers having a total attachment surface area equal to that of the modified dextran microbeads are used, the inoculum cell content need only be less than about 5% of the final number of cells harvested. This reduction in inoculum size is an immense advantage in large scaleproduction of tissue cells and cell products, in that production from a single culture can be increased by a factor of approximately 6 to 10, and contamination and reseeding problems are diminished.
The effectiveness of fiber or porous matrix microcarriers with low concentrations of cell inocula is not obvious, and is an important discovery. The explanation for this superior effectiveness is as follows:In a microcarrier suspension culture, for confluent cell growth to occur on an individual microcarrier particle, a minimum number of inoculum cells must collide with and fix themselves to that microcarrier particle. This minimum number of cells will depend to some extent on the cell type, however a typical number is 7 cells per microcarrier particle. (Fleiscschaker, J., pg 171, Ph.D Thesis June 1982, M.I.T. Dept., of Nutrition (FoodSceince).Because the collisions between microcarrier particles and inoculum cells are purely random processes, the fraction of microcarrier particles (fj) experiencing collisions with any number (i) of cells can be estimated by the Poisson Distribution (Equation I): fj = A(ei (i) ) (I) where i r the number of inoculant cells colliding with a microcarrier particle r average number of inoculum per microcarrier particle, or, inoculum cells per milliliter/microcarrierparticles per milliliterIf "n" collisions are required to initiate confluent growth, it follows that the fraction (P), of microcarriers experiencing confluent growth will be one minus the fraction of microcarriers having fewer than n collisions.
P= 1 En-1 (f) (II)when n = 7, and 105 cells/ml are inoculated on a normal concentration of 3 x 104 microcarrier bead particles per milliliter, 15 then 2, in equation I, is equal to 3.3 cells/microcarrier particle. From equation (I), the fractions of particles experiencing zero to six collisions are found to be: f,=.O; f, =.12; f,=.20; f, = .22; f,=.18; f,=.12; f,= 0.7; consequently equation (II) becomes: P=1-(f0+f1+f2+f3+f4+f5+f6) = 0.05 meaning that only one particle in 20 will have 7 or more collisions, and experience confluent cell growth. This culture will therefore fail. Such is in fact the general experience when attempting to inoculate conventional microcarrier cultures at these dilute cell concentrations and conditions (Fleiscschaker ibid. pg. 117).
This statistical reasoning explains the striking superiority of porous or fiber matrix microcarriers. Typically such carriers are 2.0 mm diameter microdiscs stamped from a 150 urn thick non-woven sheet composed of 10 urn diameter polyester fibers. The sheet presents an area for cell attachment of more than 3000 cm2/gram of sheet material. A concentration of 50 such microdiscs per milliliter of culture solution furnishes the same cell attachment area as 3 x 104 conventional microcarrier beads per milliliter. At 105 cells/ml inoculant concentration the average number of inoculant cells per microdisc, (2), is now 105/50, or 2000 cells/per microdisc (in contrast to 3.3 cells per microbead).
The collision frequency of a microdisc with these 2000 cells is magnitudes higher than that of a dextran microcarrier bead with its 3.3 cells. In fact insertion of 2 = 2000 in equation (I) shows that disc particles having fewer than even 100 cell collisions are vanishingly rare. Consequently at the same inoculant concentration and surface anchorage area, the probability of a microdisc experiencing more than 100 cell collisions is given by equation II as P is approximately equal to one. Therefore all the microdisc carriers are bombarded with cells and their growth surface reaches saturation on exposure to dilute inocula. Experimentally, 1% inoculation has succeeded in producing confluent growth.
This effect cannot be reproduced with microbeads or non-porous carriers because reducing the number of microbeads reduces the surface available for cell attachment hence microbead suspension culture is limited to a heavy inoculum.
Examples 1. Material to be used for cells culture matrices were first passed through a discharge from a plasma torch andwashed with methanol. The materials were sterilized under a UV light then immersed in a solution of 100 lig/ml poly-D-lysine, and rinsed with sterile water. Cell culture was carried out at 37"C, in an atmosphere of5% CO2 in air.
2. Unwoven sheets of polyester (0.15 mm nominal thickness, 15 urn fibers) or polypropylene (0.15 mm nominalthickness, 12 urn fibers) were cut into 30 mm diameter circles, and laid on the bottom of 30 mm petri dishes.
The same size tissue culture dishes were used as controls. Human dipolid fibroblasts (lung) (1.5 x 105 cells)were seeded in each plate with 2.5 ml of DMEM (Dulbeco modified Eagle's medium) + 10% serum and theprogress of the cultures was examined microscopically. It was observed (Figure 1) that the cells formed amulti-layered, tissue like structure. The culture was continued until the cells appeared as a congruent mass,whereupon the number of cells in each plate was determined by measuring the amount of DNA. The results(Table 1) show that 7-10 times more cells were obtained in the polymer matrix than on an equal projectedarea of a regular culture dish.
TABLE IMatrix No. cells/Cm 2 Level of confluencyas observed by microscopePolypropylene 4 x 105 70%Polyester 6 x 105 60%Nunc TC. dish 4 x 104 100%Sheets of non-woven fabric were cut into 21 x 34 cm rectangles, which were attached as 'lines' to the inside of 850 cm2 corning roller bottles. Uncoated roller bottles were used as controls. The fabric lined bottles wereeach seeded with 1) 0.3 x 107, 2)1 x 107 and 3)1.5 x 107 cells. The uncoated bottles were seeded with1.5 x 107 cells each. All bottles were then half-filled with medium, and cultures were carried out on a rotatingBelleo Roller apparatus 0.5/rev/min. Medium was replaced with fresh medium at 2 day intervals.Theuncoated bottle reached confluence, as judged by microscopic examination after 3 days and contained a cellcount of 5.7 x 107 cells. The 'lined' bottles were cultured for an additional 5 days. DNA determinationsshowed that 3-5 x 108 cells were obtained in each fabric lined bottle, irrespective of the amount seeded.
4. Sheets 200 cm long and 21 cm wide of non-woven fabric were laminated to a polypropylene screen (1 mmopening, 0.6 mm thick). The laminate was rolled into a spiral and placed within a roller bottle against the innersurface to form a spiral lining 7 layers deep. The roller bottles were seeded each with 1.5 x 107 cells, and halffilled with medium. The progress of culture was followed by removing periodically a piece of the liner, and thegrowth medium was replaced periodically (based on analysis of glucose and lactic acid) to avoid nutrientexhaustion. The cell proliferated with an average doubling time of 1.2 days and reached after 12 daysapproximately 4 x 109 cells per bottle.
5. Cell culture on non-woven fabrics in a flow-through reactor were tested in a laboratory scale assemblydepicted in Figure 5. Polypropylene or polyester support matrix was introduced into the reactor chamber(Figure 5) in wither of the following forms. i) Stacked circles of a laminate of the unwoven fabric andpolypropylene screens. Round holes, 3 mm diameter, were punched (1 or 5 holes per circle) in each circle toallow medium flow (Figure 4). ii) A rectangle of laminate was rolled into a tight spiral which fitted snugly intothe reactor chamber (Figure 4).
The cells were seeded into the reactor with enough growth medium to cover the matrix. The reactor wasclosed and the reservoir was filled with medium. After 4 hours of static incubation, medium circulation wasstarted. Pump speed was adjusted to give an initial medium residence time of 25 mins, and as the cellsproliferated pumping rate was increased to decrease residence time to about 1 min. The reactor chamber wassampled periodically, by taking out a piece of support, and determining DNA. After 8 days of culture the celldensity in the reactor chamber reached 2 x 106 cells/ml with stacked circles and nearly 7 x 106 cells/ml withthe spiral.
6. Flocks of fibers of rayon (18 urn thick, 0.5 - 2 mm long), nylon (15 urn 0.5 - 1.5 mm) and acrylic (10 - 20u x0.2 -1 mm) were treated as in Example 1. One tenth g. of each was layered on the bottem of 50 mm petridishes, seeded with cells and covered with 3 ml of DMEM + 10% serum. The number of cells that attached tothe fiber layer was determined after 24 hours. The attachment efficiency was 15-20% on the acrylic fibers, 35%on the rayon, and nearly 60% on the nylon fibers. A control with a regular tissue culture dish gave 70%attachment efficiency.
7. Sheets of non-woven fabric (400 cm2) were cut into small squares (approximately 3 x 3 mm) and loadedinto Techne 200 ml culture vessel with 100 ml of medium. Bottles were seeded with 1 x 106, 5 X 106 and 1.5 X 107 cells each. Stirring was 30 rpm, and for the first 4 hours the stirrer was on for 30 min and off for 5 min.
After that stirring was continuous. On the third day after seeding 70 ml of medium were replaced with freshmedium and thereafter 35 ml were replaced daily. Cell counts were carried our daily by DNA determination.
Cell attachment determined 24 hours after seeding was on the average 67% (56-81%) independent ofseeding density. The runs were continued for 4 days after seeding and cell doubling time was on the averageabout 32 hours. Final cell counts indicated that the cells in each bottle had increased approximately 10 times,and that the rate of increase was insensitive to low concentration of inoculum.
8. Two millimeter diameter microdiscs were punched from a non-woven fiber sheet composed of 1.5 devices perfilament polyester fibers and 15 devices per filament hollow polypropylene fibers, using a heated die thatthermally bonded the edges of the discs in the manner shown in Figure 2a giving the disc a doubly convex orlens-like appearance. The discs were then treated as in Example 1, and placed into Techne 200 ml stirredculture bottles at a concentration of 50 particles per ml in 100 ml of medium. IMR-90 human lung fibroblastcells were inoculated at a concentration of 105 cells/ml.
Stirring was intermittent and then continuous as in Example 7. Medium was replaced as in Example 7. After 8days, cells were counted and were found to have a concentration of 4 x 106 cells per milliliter, proving that aninoculation of 2.5% of final concentration was feasible.
9. A spiral laminated structure comprised of two flattened, one-inch-wide, cellulose dialysis tubes (13); to stripsof surface treated non-woven polyester fabric (11) (1 Oum fiber diameter); and four strips of polypropylenespacer screening (12) (0.6 um diameter monofilament, 1 mm opening) was assembled in the form shown inFigure 6 where, each flattened tube (13) had within itself a strip of spacer screening (12), and was bound onits external flat surfaces by a strip of non-woven fiber-grwoth matrix (11) and spacer screen (12). The entireassembly was placed in a sterile container (16) and imersed in growth medium (17) as shown in Figure 7.
The dialyses tubes were each 50 cm long. Nutritional medium without serum was pumped through oneflattened tube at a linear flow rate of about 1 cm per second. A sterile mixture of air and 5% CO2 was pumpedthrough the other flattened permeable spiral tube. By suitable means the discharge flow from the gas tube wasrestricted at two minute intervals so as to cause the spiral tube carrying the gas to periodically swell andcontract so as to cause a gentle, reversible, periodic displacement of the growth medium in which the spiral isimmersed.
The laminated spiral assembly of fiber growth matrix, spacers, and tube, was immersed in 100 ml of DMEMgrowth medium containing 10% serum. Hybridomas were inoculated into the serum containing growth medium at a density of 1.5 x 105 cells/ml. After nine days the cell concentration in the immersion medium had grown to above 107 cells/ml. The circulating medium contained no serum. The immersion growth medium contained serum and was perfused at a rate that replaced the serum once every 24 hours. After nine days, when full growth had been attained the immersion growth medium was changed to a production immersion medium that contained no serum. The perfusion rate was continued with removal of mono-clonal antibody from the immersion medium. The concentration of monoclonal antibody remained stable for 6 weeks at which time the experiment was stopped, although it could have continued.
The spiral assembly separated the growth medium, nutrient medium and gas channels, allowing each to be perfused separately which mass-transfer diffusive contact was maintained among the channels. Serum was conserved and antibody titer was maintained at an optimal level.
LEGENDS TO THE FIGURESFigures 1 A & B Fibroblasts grown on polyester sheets.
Discs of polyester sheets were cut to fit into 30 mm petri dish. Cells were seeded and allowed toproliferate for (A) 4 days (B) 12 days. The cells were then fixed and stained with gimza stain formicroscopic obervation.
Figure 2 Matrix sheet (1) laminated to polypropylene screen (2).
Figure 2A Doubly convex suspension culture fibrous microdisc comprised of randomly oriented filamentsof variety of polymers some of which are capable of thermal bonding, and some of which arehollow and open ended entrapping air or gas bubbles whose size and buoyancy is determined byexternal pressure in the suspension culture vessel. The thermally bonded edge-formed by stmping through a heated die or punch.
Figure 2B Hollow fiber showing gas bubbles trapped in lumen.
Figure 3 Spiral sheets of matrix inside roller bottle.
Matrix sheets (1), Polyproylene screen (2)Figure 4 Matrix sheets as packing in column.
A-circular -B. Spiral. Matrix sheets (1), Polypropylene screen (2).
Figure 5 Laboratory scale reactor with medium perfusion.
Figure 6 Spiral assembly of growth matrix and flatten ed permeable tubes carrying nutrient medium andair. Cell growth occurs in the matrix laminated ourside the flattened tubes.
Figure 7 Laminated spiral assembly as in Figure 6, shown inserted in sterile contained containingimmersion growth medium, said container having suitable connections for perfusing all fluidchannels.
Figure 7a Cross-section of laminated spiral assembly of Figure 6 and 7.
Figure 8 Laminated stack of growth matrix sheets interleaved with flattened medium and gas tubes, andseparator screens.

Claims (32)

25. A system for in vitro high density culture or growth of cells that is comprised of layers of matrix sheets as hereinbefore described and within which cells are entrapped or anchored, and between which matrix sheet layers are interleaved flattened permeable or microporous tubular conduits through which nutrient medium is conducted, and other permeable microporous flattened tubular conduits serving as channels for air and other gases, said layered interleaved structures arranged in a stack or spiral that is immersed in nutrient medium contained in a suitable sterile housing for introducing and withdrawing cells and fresh and spent liquids and gases, and provided with means for monitoring temperature, pH, glucose concentration and other paramaters of the culture system, all cell growth occurring in the fluid medium outside the flattened, permeable sided, interlayered, tubular channels and largely on the interleaved layers of hereinbefore described matrix sheets.
GB8614799A1985-06-181986-06-18A system for cell cultivation in vitro.ExpiredGB2178447B (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
IL75554AIL75554A (en)1985-06-181985-06-18Matrix for cell cultivation in vitro

Publications (3)

Publication NumberPublication Date
GB8614799D0 GB8614799D0 (en)1986-07-23
GB2178447Atrue GB2178447A (en)1987-02-11
GB2178447B GB2178447B (en)1989-12-28

Family

ID=11056003

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB8614799AExpiredGB2178447B (en)1985-06-181986-06-18A system for cell cultivation in vitro.

Country Status (3)

CountryLink
JP (1)JPH0829077B2 (en)
GB (1)GB2178447B (en)
IL (1)IL75554A (en)

Cited By (45)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB2221920A (en)*1988-08-041990-02-21Ion Tech LtdCell culture apparatus
EP0263371A3 (en)*1986-10-041990-05-23Akzo N.V.Process and apparatus for animal cell culture
US4937196A (en)*1989-08-181990-06-26Brunswick CorporationMembrane bioreactor system
WO1990010018A1 (en)*1989-02-231990-09-07Creative Biomolecules, Inc.Bone collagen matrix for implants
EP0435871A4 (en)*1988-07-051991-05-14Albert J BanesFloating cell culture device and method.
EP0451706A1 (en)*1990-04-061991-10-16Sakai Engineering Co., Ltd.Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein
EP0380610A4 (en)*1988-05-231991-12-18Regents Of The University Of MinnesotaBioreactor device
EP0462426A1 (en)*1990-06-011991-12-27FIDIA S.p.A.Biocompatible perforated membranes and their use as artificial skin
US5108753A (en)*1988-04-081992-04-28Creative BiomoleculesOsteogenic devices
EP0475303A3 (en)*1990-09-071992-07-01The Dow Chemical CompanyGrowth of cells in hollow fibers in an agitated vessel
WO1992018609A1 (en)*1991-04-121992-10-29VitoMembranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds
US5162225A (en)*1989-03-171992-11-10The Dow Chemical CompanyGrowth of cells in hollow fibers in an agitated vessel
US5162114A (en)*1989-02-231992-11-10Stryker CorporationBone collagen matrix for xenogenic implants
US5168058A (en)*1987-04-031992-12-01Yeda Research And Development Company, Ltd.Cell culture carriers and method of use
WO1993012877A1 (en)*1991-12-201993-07-08Allied-Signal Inc.Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals
US5254471A (en)*1986-10-061993-10-19Toray Industries, Inc.Carrier for cell culture
US5266683A (en)*1988-04-081993-11-30Stryker CorporationOsteogenic proteins
GB2252562B (en)*1990-03-051994-04-20Smith & NephewWound dressing comprising cultured cells
WO1994012614A1 (en)*1992-11-251994-06-09Cultor Ltd.Bioreactor with immobilized lactic acid bacteria and the use thereof
US5354557A (en)*1988-04-081994-10-11Stryker CorporationOsteogenic devices
US5476783A (en)*1992-03-231995-12-19Koch Engineering Company, Inc.Bioreactor method of culturing and propagating cells with a woven motionless mixing element
US5502082A (en)*1991-12-201996-03-26Alliedsignal Inc.Low density materials having good compression strength and articles formed therefrom
US5501971A (en)*1993-01-291996-03-26New Brunswick Scientific Co., Inc.Method and apparatus for anchorage and suspension cell culture
US5508174A (en)*1993-06-181996-04-16The United States Of America As Represented By The Secretary Of The Air ForceMethod and micro roller bottle for in vitro exposure of cells to volatile chemicals
US5525710A (en)*1991-12-201996-06-11Alliedsignal Inc.Highly porous chitosan bodies
EP0671469A3 (en)*1994-03-091996-12-18Japan Res Dev Corp Support penetrating a cell culture medium, culture method and apparatus using this support.
US5605835A (en)*1988-05-231997-02-25Regents Of The University Of MinnesotaBioreactor device with application as a bioartificial liver
EP0743979A4 (en)*1994-02-041997-03-12Difco LabMicrobiological culture bottle, and method of making and using same
US5645591A (en)*1990-05-291997-07-08Stryker CorporationSynthetic bone matrix
US5702945A (en)*1995-02-151997-12-30Heraeus Instruments GmbhCulture vessel for cell cultures on a carrier
US5776747A (en)*1994-07-201998-07-07Cytotherapeutics, Inc.Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
US5786215A (en)*1987-05-201998-07-28Baxter International Inc.Method for culturing animal cells
US5843431A (en)*1994-07-201998-12-01Cytotherapeutics, Inc.Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
US5955353A (en)*1997-05-221999-09-21Excorp Medical, Inc.Hollow fiber bioreactor with an extrafilament flow plug
AU714517B2 (en)*1995-10-062000-01-06Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch CentrumSolid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system
US6013511A (en)*1993-11-052000-01-11VitoPrecipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms
US6194198B1 (en)*1998-11-242001-02-27Bonno KoersDevice for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device
US6495364B2 (en)1995-05-232002-12-17Neurotech, S.A.Mx-1 conditionally immortalized cells
US6586388B2 (en)1988-04-082003-07-01Stryker CorporationMethod of using recombinant osteogenic protein to repair bone or cartilage defects
WO2004067733A1 (en)*2003-01-312004-08-12Himedica LimitedImprovements in and relating to cell growth
WO2003092982A3 (en)*2002-05-042004-12-09Membrana GmbhMethod for producing foamed polymer moulded bodies and foamed polymer moulded bodies
US6919308B2 (en)1988-04-082005-07-19Stryker CorporationOsteogenic devices
WO2015155493A1 (en)*2014-04-102015-10-15J R Biomedical LimitedApparatus for the culture of parasites
US9896563B2 (en)2005-08-102018-02-20Toray Industries, Inc.Process for producing spongelike structure
US12102944B2 (en)2008-10-172024-10-01Bioair Solutions LlcMethod of reducing the concentration of hydrogen sulfide in a gas stream

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPH0746988B2 (en)*1986-03-141995-05-24日東電工株式会社 Cultivation method and culture device for adherent animal cells
JPH01179685A (en)*1988-01-071989-07-17Kirin Brewery Co Ltd Cell culture container and its inner surface treatment method
JPH07114686B2 (en)*1989-06-261995-12-13明治乳業株式会社 Circulating culture device
US6245345B1 (en)*1998-07-072001-06-12Atrix Laboratories, Inc.Filamentous porous films and methods for producing the same
JP4555967B2 (en)2004-08-172010-10-06国立大学法人九州工業大学 Porous sheet for cell culture, bioreactor using the same, and culture method
US7655070B1 (en)*2006-02-132010-02-02Donaldson Company, Inc.Web comprising fine fiber and reactive, adsorptive or absorptive particulate
AU2007245453B2 (en)*2006-04-282013-11-28Reinnervate LimitedSubstrate for the growth of cultured cells in three dimensions
US9101686B2 (en)2010-03-022015-08-11Fujifilm CorporationCell support and bone regeneration material
AU2011258295B2 (en)2010-05-252015-01-29Cook Biotech IncorporatedMethods, substrates, and systems useful for cell seeding of medical grafts
JP5868601B2 (en)*2011-03-232016-02-24フタムラ化学株式会社 Scaffolding material for liquid medium
SG11201606729XA (en)*2014-02-142016-09-29Nissan Chemical Ind LtdActive-ester-group-containing composition for producing fibers, and cell culture scaffold material using fibers produced from active-ester-group-containing composition
CN109153954A (en)*2016-05-052019-01-04泰尔茂比司特公司Automated production and collection
JP7009957B2 (en)*2017-11-282022-01-26東洋紡株式会社 Cell culture container and cell culture device
US20210130760A1 (en)*2017-12-202021-05-06Univercells Technologies S.A.Bioreactor and related methods
CA3125540A1 (en)*2019-01-042020-07-09Premas Biotech Private LimitedDevice and method for multidimensional cell culture

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1387649A (en)*1971-12-071975-03-19Rhone Poulenc SaOrganosilicon polymer membrane
GB1491261A (en)*1974-05-171977-11-09Community Blood CouncilCell-containing hollow fibres and use of same for metabolic processes
GB1514906A (en)*1976-04-121978-06-21Monsanto CoCell culture reactor and method
GB2062006A (en)*1979-09-181981-05-20Asahi Chemical IndCultivating floating animal cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS62502936A (en)*1985-04-041987-11-26ベラツクス コ−ポレ−シヨン Microsponges and bioreactors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1387649A (en)*1971-12-071975-03-19Rhone Poulenc SaOrganosilicon polymer membrane
GB1491261A (en)*1974-05-171977-11-09Community Blood CouncilCell-containing hollow fibres and use of same for metabolic processes
GB1514906A (en)*1976-04-121978-06-21Monsanto CoCell culture reactor and method
GB2062006A (en)*1979-09-181981-05-20Asahi Chemical IndCultivating floating animal cells

Cited By (72)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0263371A3 (en)*1986-10-041990-05-23Akzo N.V.Process and apparatus for animal cell culture
US5254471A (en)*1986-10-061993-10-19Toray Industries, Inc.Carrier for cell culture
US5168058A (en)*1987-04-031992-12-01Yeda Research And Development Company, Ltd.Cell culture carriers and method of use
US5786215A (en)*1987-05-201998-07-28Baxter International Inc.Method for culturing animal cells
US5354557A (en)*1988-04-081994-10-11Stryker CorporationOsteogenic devices
US5468845A (en)*1988-04-081995-11-21Stryker CorporationAntibodies to osteogenic proteins
US5958441A (en)*1988-04-081999-09-28Stryker Biotech CorporationDevices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith
US6551995B1 (en)1988-04-082003-04-22Stryker CorporationOsteogenic devices
US7176284B2 (en)1988-04-082007-02-13Stryker CorporationOsteogenic proteins
US5108753A (en)*1988-04-081992-04-28Creative BiomoleculesOsteogenic devices
US6919308B2 (en)1988-04-082005-07-19Stryker CorporationOsteogenic devices
US5266683A (en)*1988-04-081993-11-30Stryker CorporationOsteogenic proteins
US5863758A (en)*1988-04-081999-01-26Stryker CorporationNucleic acids encoding osteogenic proteins
US6586388B2 (en)1988-04-082003-07-01Stryker CorporationMethod of using recombinant osteogenic protein to repair bone or cartilage defects
EP0380610A4 (en)*1988-05-231991-12-18Regents Of The University Of MinnesotaBioreactor device
US5605835A (en)*1988-05-231997-02-25Regents Of The University Of MinnesotaBioreactor device with application as a bioartificial liver
US5981211A (en)*1988-05-231999-11-09Regents Of The University Of MinnesotaMaintaining cells for an extended time by entrapment in a contracted matrix
EP0435871A4 (en)*1988-07-051991-05-14Albert J BanesFloating cell culture device and method.
GB2221920A (en)*1988-08-041990-02-21Ion Tech LtdCell culture apparatus
US5162114A (en)*1989-02-231992-11-10Stryker CorporationBone collagen matrix for xenogenic implants
US5171574A (en)*1989-02-231992-12-15Stryker CorporationBone collagen matrix for implants
US4975526A (en)*1989-02-231990-12-04Creative Biomolecules, Inc.Bone collagen matrix for zenogenic implants
WO1990010018A1 (en)*1989-02-231990-09-07Creative Biomolecules, Inc.Bone collagen matrix for implants
US5162225A (en)*1989-03-171992-11-10The Dow Chemical CompanyGrowth of cells in hollow fibers in an agitated vessel
US4937196A (en)*1989-08-181990-06-26Brunswick CorporationMembrane bioreactor system
GB2252562B (en)*1990-03-051994-04-20Smith & NephewWound dressing comprising cultured cells
EP0451706A1 (en)*1990-04-061991-10-16Sakai Engineering Co., Ltd.Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein
US6605117B2 (en)1990-05-292003-08-12Stryker CorporationSynthetic bone matrix
US6468308B1 (en)1990-05-292002-10-22Stryker CorporationSynthetic bone matrix
US5645591A (en)*1990-05-291997-07-08Stryker CorporationSynthetic bone matrix
US5650164A (en)*1990-06-011997-07-22Fidia S.P.A.Process for preparing artificial skin with biocompatible perforated membranes
US5326356A (en)*1990-06-011994-07-05Fidia S.P.A.Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
US5658331A (en)*1990-06-011997-08-19Fidia S.P.A.Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
EP0462426A1 (en)*1990-06-011991-12-27FIDIA S.p.A.Biocompatible perforated membranes and their use as artificial skin
EP0475303A3 (en)*1990-09-071992-07-01The Dow Chemical CompanyGrowth of cells in hollow fibers in an agitated vessel
WO1992018609A1 (en)*1991-04-121992-10-29VitoMembranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds
US5494940A (en)*1991-12-201996-02-27Alliedsignal Inc.Low density materials having high surface areas and articles formed therefrom
US5502082A (en)*1991-12-201996-03-26Alliedsignal Inc.Low density materials having good compression strength and articles formed therefrom
US5541234A (en)*1991-12-201996-07-30Alliedsignal Inc.Process for making low density hydrogel materials having high surface areas
WO1993012877A1 (en)*1991-12-201993-07-08Allied-Signal Inc.Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals
US5525710A (en)*1991-12-201996-06-11Alliedsignal Inc.Highly porous chitosan bodies
US5565361A (en)*1992-03-231996-10-15Koch Engineering Company, Inc.Bioreactor for culturing and propagating cells with a woven motionless mixing element
US5476783A (en)*1992-03-231995-12-19Koch Engineering Company, Inc.Bioreactor method of culturing and propagating cells with a woven motionless mixing element
US5635368A (en)*1992-11-251997-06-03Cultor Ltd.Bioreactor with immobilized lactic acid bacteria and the use thereof
WO1994012614A1 (en)*1992-11-251994-06-09Cultor Ltd.Bioreactor with immobilized lactic acid bacteria and the use thereof
US5501971A (en)*1993-01-291996-03-26New Brunswick Scientific Co., Inc.Method and apparatus for anchorage and suspension cell culture
US5508174A (en)*1993-06-181996-04-16The United States Of America As Represented By The Secretary Of The Air ForceMethod and micro roller bottle for in vitro exposure of cells to volatile chemicals
US6013511A (en)*1993-11-052000-01-11VitoPrecipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms
EP0743979A4 (en)*1994-02-041997-03-12Difco LabMicrobiological culture bottle, and method of making and using same
US5736399A (en)*1994-03-091998-04-07Research Development Corporation Of JapanMedium-penetrating cell culture carrier, a culturing method and a device using this carrier
EP0671469A3 (en)*1994-03-091996-12-18Japan Res Dev Corp Support penetrating a cell culture medium, culture method and apparatus using this support.
US5776747A (en)*1994-07-201998-07-07Cytotherapeutics, Inc.Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
US5843431A (en)*1994-07-201998-12-01Cytotherapeutics, Inc.Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
US5935849A (en)*1994-07-201999-08-10Cytotherapeutics, Inc.Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5795790A (en)*1994-07-201998-08-18Cytotherapeutics, Inc.Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US5858747A (en)*1994-07-201999-01-12Cytotherapeutics, Inc.Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
US5833979A (en)*1994-07-201998-11-10Cytotherapeutics, Inc.Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5840576A (en)*1994-07-201998-11-24Cytotherapeutics, Inc.Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6392118B1 (en)1994-07-202002-05-21Neurotech S.A.Mx-1 conditionally immortalized cells
US5853717A (en)*1994-07-201998-12-29Cytotherapeutics, Inc.Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5702945A (en)*1995-02-151997-12-30Heraeus Instruments GmbhCulture vessel for cell cultures on a carrier
US6495364B2 (en)1995-05-232002-12-17Neurotech, S.A.Mx-1 conditionally immortalized cells
US6372495B1 (en)*1995-10-062002-04-16Seed Capital Investments-2 (Sci-2) B.V.Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen
AU714517B2 (en)*1995-10-062000-01-06Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch CentrumSolid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system
US5955353A (en)*1997-05-221999-09-21Excorp Medical, Inc.Hollow fiber bioreactor with an extrafilament flow plug
US6194198B1 (en)*1998-11-242001-02-27Bonno KoersDevice for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device
WO2003092982A3 (en)*2002-05-042004-12-09Membrana GmbhMethod for producing foamed polymer moulded bodies and foamed polymer moulded bodies
US7429420B2 (en)2002-05-042008-09-30Membrana GmbhMethod for producing foamed polymer molded bodies and said foamed polymer molder bodies
WO2004067733A1 (en)*2003-01-312004-08-12Himedica LimitedImprovements in and relating to cell growth
US9896563B2 (en)2005-08-102018-02-20Toray Industries, Inc.Process for producing spongelike structure
US12102944B2 (en)2008-10-172024-10-01Bioair Solutions LlcMethod of reducing the concentration of hydrogen sulfide in a gas stream
WO2015155493A1 (en)*2014-04-102015-10-15J R Biomedical LimitedApparatus for the culture of parasites

Also Published As

Publication numberPublication date
GB2178447B (en)1989-12-28
GB8614799D0 (en)1986-07-23
JPS62122586A (en)1987-06-03
IL75554A (en)1993-01-14
IL75554A0 (en)1985-10-31
JPH0829077B2 (en)1996-03-27

Similar Documents

PublicationPublication DateTitle
US5266476A (en)Fibrous matrix for in vitro cell cultivation
GB2178447A (en)A matrix for cell cultivation in vitro
CA2244659C (en)Biological reactor for the cultivation of cells
US5149649A (en)Multi-layered porous hollow fiber membrane for use in cell culture
US5786215A (en)Method for culturing animal cells
JP3246664B2 (en) Scaffold and method for culturing suspended cells and apparatus therefor
AU777290B2 (en)Culture chamber
US5376548A (en)Bioreactor apparatus
US6228607B1 (en)Bioreactor
EA009716B1 (en)Cell cultivation method
US20040067585A1 (en)Cell cultivation surface and method of making the same
EP1425379B1 (en)Method and structure for growing living organic tissue
EP0123326A2 (en)Method for cell culture growth
WO2002031108A1 (en)Cell culture case
JP7619715B2 (en) Carrier for cell biomass production and cell culture device including same
JP2024501108A (en) Packed bed bioreactor with controlled area porosity
DE102010005415B4 (en) Method and device for the dynamic expansion and / or differentiation of suspended primary cells or stem cells of human and animal origin
JP2619885B2 (en) Cell culture method and device
JP4262695B2 (en) Membrane biodevice and bioreactor
JP2001178445A (en)Carrier for culturing three-dimensional animal cell and three-dimensional animal cell
US20240287431A1 (en)Rolled cell culture substrates for fixed bed bioreactors with controlled perfusion zones
JP3139794B2 (en) Hollow fiber membrane cell culture device
JPS62118878A (en)Cell culture unit
JPH0568230B2 (en)
JPH0352954B2 (en)

Legal Events

DateCodeTitleDescription
PE20Patent expired after termination of 20 years

Effective date:20060617


[8]ページ先頭

©2009-2025 Movatter.jp